Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inogen (INGN) EBIT (2016 - 2026)

Inogen has reported EBIT over the past 13 years, most recently at $16.0 million for Q4 2025.

  • Quarterly EBIT rose 240.45% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.9 million through Dec 2025, up 88.45% year-over-year, with the annual reading at -$4.9 million for FY2025, 88.45% up from the prior year.
  • EBIT was $16.0 million for Q4 2025 at Inogen, up from -$7.1 million in the prior quarter.
  • Over five years, EBIT peaked at $16.0 million in Q4 2025 and troughed at -$58.5 million in Q4 2022.
  • The 5-year median for EBIT is -$7.7 million (2024), against an average of -$11.6 million.
  • Year-over-year, EBIT surged 596.43% in 2021 and then crashed 776.5% in 2022.
  • A 5-year view of EBIT shows it stood at -$6.7 million in 2021, then crashed by 776.5% to -$58.5 million in 2022, then soared by 50.45% to -$29.0 million in 2023, then skyrocketed by 60.71% to -$11.4 million in 2024, then soared by 240.45% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's EBIT are $16.0 million (Q4 2025), -$7.1 million (Q3 2025), and -$6.1 million (Q2 2025).